SHPK and leukemia: SHK and its derivatives showed potent anti-leukemia effect, and downregulation of c-Myc was identified as the most commonly mechanism in a series of leukemia cell lines (U937, Jurkat, Molt4, CCRF-CEM, and multidrug-resistant CEM/ADR5000) (Zhao et al., 2015).